Cercar

01/04/2024 Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists
Mauricio, D, Escalada, J, Pérez, A, Romero-Gómez, M, Cusi, K, Younoussi, ZM, Lazarus, JV. Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists. Endocrinologia Diabetes y Nutricion. 2024; 71(4)DOI:10.1016/j.endien.2024.01.007. PMID:38735676. IF:1.800(Q3/8D).
29/03/2024 Lipidome characterisation and sex-specific differences in type 1 and type 2 diabetes mellitus
Barranco-Altirriba, M, Alonso, N, Weber, RJM, Lloyd, GR, Hernandez, M, Yanes, O, Capellades, J, Jankevics, A, Winder, C, Falguera, M, Franch-Nadal, J, Dunn, WB, Perera-Lluna, A, Castelblanco, E, Mauricio, D. Lipidome characterisation and sex-specific differences in type 1 and type 2 diabetes mellitus. Cardiovascular Diabetology. 2024; 23(1)DOI:10.1186/s12933-024-02202-5. PMID:38553758. IF:10.600(Q1/1D).
18/03/2024 Modulatory actions of Echinococcus granulosus antigen B on macrophage inflammatory activation
Folle, AM, Magallanes, SL, Fló, M, Alvez-Rosado, R, Carrión, F, Vallejo, C, Watson, D, Julve, J, González-Sapienza, G, Pristch, O, González-Techera, A, Ferreira, AM. Modulatory actions of Echinococcus granulosus antigen B on macrophage inflammatory activation. Frontiers in Cellular and Infection Microbiology. 2024; 14DOI:10.3389/fcimb.2024.1362765. PMID:38562963. IF:4.800(Q1/2D).
07/03/2024 Postpartum oral glucose tolerance test in women with prior gestational diabetes. Does breastfeeding affect the results? Analysis of hormonal profiles
Monroy, G, Fernández, C, Altimira, L, Barba, U, Corcoy, R. Postpartum oral glucose tolerance test in women with prior gestational diabetes. Does breastfeeding affect the results? Analysis of hormonal profiles. DIABETIC MEDICINE. 2024; 41(6)DOI:10.1111/dme.15315. PMID:38451734. IF:3.400(Q2/4D).
01/03/2024 Gestational weight gain in women with type 1 and type 2 diabetes mellitus is related to both general and diabetes-related clinical characteristics
Xie X., Liu J., García-Patterson A., Chico A., Mateu-Salat M., Amigó J., Adelantado J.M., Corcoy R.. Gestational weight gain in women with type 1 and type 2 diabetes mellitus is related to both general and diabetes-related clinical characteristics. Hormones-International Journal of Endocrinology and Metabolism. 2024; 23(1)DOI:10.1007/s42000-023-00497-9. PMID:37845472. IF:2.500(Q3/7D).
01/03/2024 Performance of Primary Care Physicians in the Management of Glycemia, Lipids, and Blood Pressure among People with Type 2 Diabetes: A Cross-Sectional Study
Vlacho, B, Fernandez-Camins, B, Canudas-Ventura, A, Rodríguez, A, Mollo, A, Claramunt, FXC, Antentas, M, Mauricio, D, Franch-Nadal, J. Performance of Primary Care Physicians in the Management of Glycemia, Lipids, and Blood Pressure among People with Type 2 Diabetes: A Cross-Sectional Study. Journal of Clinical Medicine. 2024; 13(6)DOI:10.3390/jcm13061544. PMID:38541770. IF:2.900(Q1/2D).
08/02/2024 Clinical characteristics and degree of cardiovascular risk factor control in patients with newly-diagnosed type 2 diabetes in Catalonia
Ramírez-Morros, A, Franch-Nadal, J, Real, J, Miró-Catalina, Q, Bundó, M, Vlacho, B, Mauricio, D. Clinical characteristics and degree of cardiovascular risk factor control in patients with newly-diagnosed type 2 diabetes in Catalonia. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1339879. PMID:38390201. IF:4.600(Q1/3D).
01/02/2024 The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia
Ma, CX, Ma, XN, Liu, JJ, Guan, CH, Li, YD, Zhao, N, Mauricio, D, Fu, SB. The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia. MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2024; 581DOI:10.1016/j.mce.2023.112113. PMID:37989409. IF:3.600(Q2/4D).
01/02/2024 A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting
Beato-Víbora, PI, Chico, A, Moreno-Fernandez, J, Bellido-Castañeda, V, Nattero-Chávez, L, Picón-César, MJ, Martínez-Brocca, MA, Giménez-Alvarez, M, Aguilera-Hurtado, E, Climent-Biescas, E, Azriel-Mir, S, Rebollo-Román, A, Yoldi-Vergara, C, Pazos-Couselo, M, Alonso-Carril, N, Quirós, C. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting. DIABETES CARE. 2024; 47(2)DOI:10.2337/dc23-1355. PMID:37948469. IF:16.600(Q1/1D).
15/01/2024 The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review
Sloan, L, Cheng, AYY, Escalada, J, Haluzík, M, Mauricio, D. The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review. DIABETES OBESITY & METABOLISM. 2024; 26(4)DOI:10.1111/dom.15425. PMID:38225217. IF:5.700(Q1/2D).
01/01/2024 Type 2 Diabetes and HDL dysfunction: a key contributor to Glycemic Control.
Rotllan N, Julve J, Escolà-Gil JC. Type 2 Diabetes and HDL dysfunction: a key contributor to Glycemic Control.. CURRENT MEDICINAL CHEMISTRY. 2024; 31(3)DOI:10.2174/0929867330666230201124125. PMID:36722477. IF:3.500(Q2/4D).
01/01/2024 The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization
Chico A., Moreno-Fernández J., Fernández-García D., Solá E.. The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization. Diabetes Therapy. 2024; 15(1)DOI:10.1007/s13300-023-01486-2. PMID:37857988. IF:2.600(Q3/6D).
01/01/2024 Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1
Rodríguez-Agudo, R, González-Recio, I, Serrano-Maciá, M, Bravo, M, Petrov, P, Blaya, D, Herranz, JM, Mercado-Gómez, M, Rejano-Gordillo, CM, Lachiondo-Ortega, S, Gil-Pitarch, C, Azkargorta, M, Van Liempd, SM, Martinez-Cruz, LA, Simao, AL, Elortza, F, Martín, C, Nevzorova, YA, Cubero, FJ, Delgado, TC, Argemi, J, Bataller, R, Schoonjans, K, Banales, JM, Castro, RE, Sancho-Bru, P, Avila, MA, Julve, J, Jover, R, Mabe, J, Simon, J, Goikoetxea-Usandizaga, N, Martínez-Chantar, ML. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1. Jhep Reports. 2024; 6(1)DOI:10.1016/j.jhepr.2023.100918. PMID:38192540. IF:7.500(Q1/2D).
01/01/2024 Trends in the prevalence of gestational diabetes in Catalonia from 2010 to 2019
Soldevila B., Alarcón L., Vlacho B., Real J., Hernández M., Cos X., Franch-Nadal J., Mauricio D.. Trends in the prevalence of gestational diabetes in Catalonia from 2010 to 2019. Primary Care Diabetes. 2024; 18(2)DOI:10.1016/j.pcd.2023.12.007. PMID:38228411. IF:2.300(Q2/5D).
01/01/2024 Ultrarapid Insulin Use Can Reduce Postprandial Hyperglycemia and Late Hypoglycemia, Even in Delayed Insulin Injections: A Connected Insulin Cap-Based Real-World Study
Gómez-Peralta, F, Valledor, X, López-Picado, A, Abreu, C, Fernández-Rubio, E, Cotovad, L, Pujante, P, García-Fernández, E, Azriel, S, Corcoy, R, Pérez-González, J, Ruiz-Valdepeñas, L. Ultrarapid Insulin Use Can Reduce Postprandial Hyperglycemia and Late Hypoglycemia, Even in Delayed Insulin Injections: A Connected Insulin Cap-Based Real-World Study. Diabetes Technology & Therapeutics. 2024; 26(1)DOI:10.1089/dia.2023.0321. PMID:37902762. IF:6.300(Q1/2D).
01/01/2024 Impact of Gender on Patient Experiences of Self-Management in Type 2 Diabetes: A Qualitative Study
Ramírez-Morros, A, Berenguera, A, Millaruelo, L, Buil-Cosiales, P, Garcia, CG, Cos, X, Lachica, LA, Artola, S, Millaruelo, JM, Mauricio, D, Franch-Nadal, J. Impact of Gender on Patient Experiences of Self-Management in Type 2 Diabetes: A Qualitative Study. Patient Preference and Adherence. 2024; 18DOI:10.2147/PPA.S466931. PMID:39290823. IF:2.000(Q2/4D).
01/01/2024 Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study
Durán-Martínez, M, Azriel, S, Doulatram-Gamgaram, VK, Moreno-Pérez, O, Pines-Corrales, PJ, Tejera-Pérez, C, Merino-Torres, JF, Brito-Sanfiel, M, Chico, A, Marco, A, García-Fernández, E, Martínez-Montoro, JI. Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study. DIABETES & METABOLISM. 2024; 50(1)DOI:10.1016/j.diabet.2023.101501. PMID:38061425. IF:4.700(Q1/3D).
01/12/2023 Is the Spanish type 1 diabetes mellitus registry really necessary?
Escalada J., Pérez A., Rica I.. Is the Spanish type 1 diabetes mellitus registry really necessary?. Endocrinologia Diabetes y Nutricion. 2023; 70(10)DOI:10.1016/j.endinu.2023.05.002. PMID:38000969. IF:1.800(Q3/8D).
01/12/2023 Vascular and Platelet Effects of Tomato Soffritto Intake in Overweight and Obese Subjects
López-Yerena, A, Padro, T, Villaplana, VD, Muñoz-García, N, Pérez, A, Vilahur, G, Badimon, L. Vascular and Platelet Effects of Tomato Soffritto Intake in Overweight and Obese Subjects. Nutrients. 2023; 15(24)DOI:10.3390/nu15245084. PMID:38140343. IF:4.800(Q1/2D).
01/12/2023 Pharmacological modulation of vascular ageing: A review from VascAgeNet
Roth, L, Dogan, S, Tuna, BG, Aranyi, T, Benitez, S, Borrell-Pages, M, Bozaykut, P, De Meyer, GRY, Duca, L, Durmus, N, Fonseca, D, Fraenkel, E, Gillery, P, Giudici, A, Jaisson, S, Johansson, M, Julve, J, Lucas-Herald, AK, Martinet, W, Maurice, P, McDonnell, BJ, Ozbek, EN, Pucci, G, Pugh, CJA, Rochfort, KD, Roks, AJM, Rotllan, N, Shadiow, J, Sohrabi, Y, Spronck, B, Szeri, F, Terentes-Printzios, D, Aydin, ET, Tura-Ceide, O, Ucar, E, Yetik-Anacak, G. Pharmacological modulation of vascular ageing: A review from VascAgeNet. AGEING RESEARCH REVIEWS. 2023; 92DOI:10.1016/j.arr.2023.102122. PMID:37956927. IF:12.500(Q1/1D).